CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MDXG — Mimedx Group, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,447,701
-$2,808,916 QoQ
Shares Held
1,379,165
+13.1% QoQ
Ownership
0.926%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. MDXG ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,447,701 | 1,379,165 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,256,617 | 1,219,589 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,199,255 | 1,031,412 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,673,329 | 1,092,198 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,767,337 | 1,153,597 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $13,444,055 | 1,397,511 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,483,196 | 1,435,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,304,710 | 1,342,671 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,019,880 | 1,171,413 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,947,048 | 1,134,213 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,847,750 | 1,076,509 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,548,639 | 990,717 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,183,071 | 933,452 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,590,543 | 931,850 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,637,512 | 918,994 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,552,209 | 735,507 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,526,028 | 748,626 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,422,959 | 732,278 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,358,455 | 719,217 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,809,617 | 704,206 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,696,161 | 455,938 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,012,851 | 441,944 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||